Immunovant
Akram Yanny is a seasoned accounting professional with extensive experience in leadership roles within the accounting and finance sectors. Currently serving as the Director of Accounting at Immunovant since June 2020, Akram has also held positions such as Associate Director and Accounting Senior Manager at the same company. Prior to Immunovant, contributions were made as a Senior Manager at CFGI and as a Revenue Recognition & Analytics Senior Manager at Quest Diagnostics. Akram's career began at Deloitte and Touche, LLP as an Audit Manager, and furthered at EY as a Financial Accounting and Advisory Services Manager. Akram's foundational skills were developed as a Senior Accountant at Integrated Processing Services, Inc. Academically, Akram earned an MBA in Accounting from Rutgers University - Newark and a B.S. in Information Technology from the New Jersey Institute of Technology.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.